SOURCE KLOwen Orthodontics
showed that dual blockade of SU11274 (c-MET inhibitor) and erlotinib (EGFR inhibitor) in HNSCC lines produce greater-than-additive inhibition of cell growth via erbB3/AKT signaling [86]
H., Petrovic, A., Sikiric, S., Vranes, H., Prtoric, A., Zizek, H., Durasin, T., Dobric, I., Staresinic, M., Strbe, S., Knezevic, M., Sola, M., Kokot, A.,
N Engl J Med 375:311322 Holman RR, Bethel MA, Mentz RJ et al (2017) SUSTAIN-6 Investigators Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes
The takeaway: Indias CDMOs have moved from supporting roles to leading the next phase of global pharma manufacturing
Rapid weight loss increases the risk of gallstones, so be alert to these symptoms